CNBXD Stock Price, News & Analysis
Company Description
CNBXD (OTC: CNBXD) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $5.9M.
CNBXD stock has gained 58.3% over the past year.
This page provides a comprehensive overview of CNBXD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CNBXD (CNBXD) stock. Over the past 12 months, the stock has gained 58.3%. At a market capitalization of $5.9M, CNBXD is classified as a micro-cap stock with approximately 1.2M shares outstanding.
Latest News
CNBXD has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all CNBXD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CNBXD Company Profile & Sector Positioning
CNBXD (CNBXD) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing CNBXD often look at related companies in the same sector, including Pasithea Therapeutics Corp (KTTA), Polyrizon Ltd (PLRZ), 60 degrees pharmaceuticals, Inc. (SXTP), Titan Pharmaceut (TTNP), and Clearmind Medici (CMND). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNBXD's relative position within its industry.